Stem Cells, Vol 11, 120-129, Copyright © 1993 by AlphaMed Press

ORIGINAL ARTICLES

Serum-free medium allows the optimal growth of human megakaryocyte progenitors compared with human plasma supplemented cultures: role of TGF beta

R Berthier, O Valiron, A Schweitzer and G Marguerie
Laboratoire d'Hematologie, INSERM U 217, Departement de Biologie Moleculaire et Structurale, CEN Grenoble, France.

The growth of human megakaryocyte progenitors from human bone marrow (BM) cells was compared using a methylcellulose semisolid assay supplemented either by normal human plasma or by a serum-free medium. Far better growth of megakaryocyte colonies from CD34+ BM cells stimulated by interleukin 3 (IL-3) and interleukin 6 (IL-6) was observed in serum-free medium compared with human plasma supplemented cultures. These results were confirmed in liquid cultures using the same serum-free medium composition. The megakaryocytes were identified by using an immunocytochemical procedure after labeling with an anti- GPIIb-IIIa monoclonal antibody. High percentages (15 to 20%) of megakaryocytes were present in serum-free cultures stimulated by IL-3 alone or combined with IL-6. The absolute number of megakaryocytes in serum-free medium exceeds by 3.3 (IL-3 plus IL-6) to 4.4 (IL-3 alone) times the corresponding number of megakaryocytes observed in human plasma supplemented cultures. The optimal concentration of IL-3 alone was 5 ng/ml, and an optimal synergistic effect of IL-6 (5 ng/ml) was obtained when combined with a suboptimal dose of IL-3 (1 ng/ml). The poor growth of megakaryocyte colonies from CD34+ BM cells in human plasma suggested the presence of an inhibitory factor. When a neutralizing monoclonal antibody against transforming growth factor beta (TGF beta) is present in human plasma supplemented cultures of CD34+ BM cells, the number of megakaryocyte colonies is increased to the level observed in corresponding serum-free cultures. The high efficiency of this serum-free medium to promote the growth of human megakaryocytes will be useful to study the effects of regulators and platelet agonists acting on human megakaryocytes, without interference from factors in the serum.

This article has been cited by other articles:

				T. Matsunaga, I. Tanaka, M. Kobune, Y. Kawano, M. Tanaka, K. Kuribayashi, S. Iyama, T. Sato, Y. Sato, R. Takimoto, et al. Ex Vivo Large-Scale Generation of Human Platelets from Cord Blood CD34+ Cells Stem Cells, December 1, 2006; 24(12): 2877 - 2887. [Abstract] [Full Text] [PDF]

				L. Teofili, M. Martini, A. Di Mario, S. Rutella, R. Urbano, M. Luongo, G. Leone, and L. M. Larocca Expression of p15ink4b gene during megakaryocytic differentiation of normal and myelodysplastic hematopoietic progenitors Blood, July 15, 2001; 98(2): 495 - 497. [Abstract] [Full Text] [PDF]

				L. Catani, M. Amabile, S. Luatti, L. Valdre, N. Vianelli, G. Martinelli, and S. Tura Interleukin-4 Downregulates Nuclear Factor-Erythroid 2 (NF-E2) Expression in Primary Megakaryocytes and in Megakaryoblastic Cell Lines Stem Cells, July 1, 2001; 19(4): 339 - 347. [Abstract] [Full Text] [PDF]

				D. Clay, E. Rubinstein, Z. Mishal, A. Anjo, M. Prenant, C. Jasmin, C. Boucheix, and M.-C. L. Bousse-Kerdiles CD9 and megakaryocyte differentiation Blood, April 1, 2001; 97(7): 1982 - 1989. [Abstract] [Full Text] [PDF]

				A. Lepage, M. Leboeuf, J.-P. Cazenave, C. de la Salle, F. Lanza, and G. Uzan The alpha IIbbeta 3 integrin and GPIb-V-IX complex identify distinct stages in the maturation of CD34+ cord blood cells to megakaryocytes Blood, December 15, 2000; 96(13): 4169 - 4177. [Abstract] [Full Text] [PDF]

				C. V. Cox, S. B. Killick, S. Patel, M. O. Elebute, J. C.W. Marsh, E. C. Gordon-Smith, and F. M. Gibson In Vitro Proliferation and Differentiation of Megakaryocytic Progenitors in Patients with Aplastic Anemia, Paroxysmal Nocturnal Hemoglobinuria, and the Myelodysplastic Syndromes Stem Cells, November 1, 2000; 18(6): 428 - 434. [Abstract] [Full Text]

				N. O. Fortunel, A. Hatzfeld, and J. A. Hatzfeld Transforming growth factor-beta : pleiotropic role in the regulation of hematopoiesis Blood, September 15, 2000; 96(6): 2022 - 2036. [Abstract] [Full Text] [PDF]

				H. Isomura, M. Yoshida, H. Namba, N. Fujiwara, R. Ohuchi, F. Uno, M. Oda, Y. Seino, and M. Yamada Suppressive effects of human herpesvirus-6 on thrombopoietin-inducible megakaryocytic colony formation in vitro J. Gen. Virol., March 1, 2000; 81(3): 663 - 673. [Abstract] [Full Text]

				J.-J. Lataillade, D. Clay, C. Dupuy, S. Rigal, C. Jasmin, P. Bourin, and M.-C. L. Bousse-Kerdiles Chemokine SDF-1 enhances circulating CD34+ cell proliferation in synergy with cytokines: possible role in progenitor survival Blood, February 1, 2000; 95(3): 756 - 768. [Abstract] [Full Text] [PDF]

				P. Tropel, V. Roullot, M. Vernet, C. Poujol, H. Pointu, P. Nurden, G. Marguerie, and D. Tronik-Le Roux A 2.7-kb Portion of the 5' Flanking Region of the Murine Glycoprotein alpha IIb Gene Is Transcriptionally Active in Primitive Hematopoietic Progenitor Cells Blood, October 15, 1997; 90(8): 2995 - 3004. [Abstract] [Full Text] [PDF]

				F. Bertolini, M. Battaglia, P. Pedrazzoli, G. Antonio Da Prada, A. Lanza, D. Soligo, L. Caneva, B. Sarina, S. Murphy, T. Thomas, et al. Megakaryocytic Progenitors Can Be Generated Ex Vivo and Safely Administered to Autologous Peripheral Blood Progenitor Cell Transplant Recipients Blood, April 15, 1997; 89(8): 2679 - 2688. [Abstract] [Full Text] [PDF]

				J. E.J. Rasko, E. O'Flaherty, and C. G. Begley Mpl Ligand (MGDF) Alone and in Combination with Stem Cell Factor (SCF) Promotes Proliferation and Survival of Human Megakaryocyte, Erythroid and Granulocyte/Macrophage Progenitors Stem Cells, January 1, 1997; 15(1): 33 - 42. [Abstract] [Full Text]

				I. Ayala, A Tomer, and K. Kellar Flow cytometric analysis of megakaryocyte-associated antigens on CD34 cells and their progeny in liquid culture Stem Cells, May 1, 1996; 14(3): 320 - 329. [Abstract]